Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anton Jorgensen

Orthopaedic Surgery San Antonio, TX Medical Doctor

NPI 1841481975 CMS profile 1385809

2833 Babcock Rd Ste 306 Twr II, San Antonio, TX 78229

Open in the dashboard

General payments

$37,902

281 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anton Jorgensen of San Antonio, TX is reported in the CMS Open Payments database as having received $37,902 across 281 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,132 21
2024 General $4,006 38
2023 General $2,583 26
2022 General $7,501 61
2021 General $2,018 27
2020 General $2,596 21
2019 General $18,067 87

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anton Jorgensen
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Anton Jorgensen were reported at $1,132. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Anton Jorgensen Orthopaedic Surgery median Middle half National median
2019 $18,067 $644 $140–$2,844 $163
2020 $2,596 $312 $75–$1,860 $114
2021 $2,018 $520 $117–$2,495 $132
2022 $7,501 $598 $128–$2,731 $149
2023 $2,583 $461 $128–$2,264 $160
2024 $4,006 $497 $134–$2,475 $164
2025 $1,132 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. SI-BONE, Inc. $7,201 43 payments
  2. Aesculap Implant Systems, LLC $6,341 26 payments
  3. Zimvie Inc. $3,303 25 payments
  4. Globus Medical, Inc. $3,299 11 payments
  5. Abbott Laboratories $2,411 23 payments
  6. Mission Medical Distribution, LLC $1,726 7 payments
  7. Cerapedics, Inc. $1,631 2 payments
  8. Medtronic USA, Inc. $1,541 9 payments
  9. Medtronic, Inc. $1,514 13 payments
  10. Integrity Implants Inc. $1,420 7 payments
  11. Other $7,515 115 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $14,597 229 payments
  2. Travel and Lodging $13,365 47 payments
  3. Consulting Fee $8,400 3 payments
  4. Honoraria $1,500 1 payment
  5. Gift $40 1 payment
Products named General payments · program years 2019–2025
  1. IFUSE IMPLANT $6,650 39 payments
  2. ACTIVL ARTIFICIAL DISC $5,979 22 payments
  3. The Tether $3,299 24 payments
  4. PROCLAIM $1,736 11 payments
  5. i-FACTOR Putty $1,631 2 payments
  6. CALIBER $1,536 4 payments
  7. OSTEOCOOL RF ABLATION $1,411 7 payments
  8. FlareHawk $1,242 4 payments
  9. Excelsius Robotics System $941 1 payment
  10. CYGNUS Anterior Cervical Plate $733 4 payments
  11. Other $12,870 170 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

315

Median for Orthopedic Surgery: 203

Drug cost

$2,112

Median for Orthopedic Surgery: $1,433

Branded share of claims

45.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 88 $837
Gabapentin Generic 46 $387
Cyclobenzaprine Hcl Generic 63 $330
Tramadol Hcl Generic 49 $242
Ondansetron Odt Ondansetron Brand 54 $217
Methylprednisolone Generic 15 $99

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$164,755

Medicare's payments for the services billed

Medicare patients

216

Average age 73

Services billed

912

125 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 34%
Diabetes 31%
Depression 31%
Chronic kidney disease 23%
Heart failure 19%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

281 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record